PPMI News

The Parkinson's Progression Markers Initiative is our landmark study launched in 2010 to deepen knowledge of Parkinson's and to better understand its onset and progression to speed the development of new treatments. Learn the latest news from the study here.

Partner Scientist Runs Marathon for Parkinson's

April 4, 2012

Chris Coffey, PhD, director of the Clinical Trials Statistical and Data Management Center at the University of Iowa ran the 2011 Bank of America Chicago Marathon.

Learn more
Bob Harmon and Family: Turning a Parkinson's Diagnosis into Action

March 26, 2012

The news of a Parkinson’s diagnosis can be very alarming. Team Fox member and mentor Bob Harmon recalls March 3, 2006 as the “day the earth stood still.”

Learn more
New Blood Test That Could Diagnose Parkinson's Is Being Studied

February 24, 2012

WebMD is reporting on a potential blood test (a.k.a. biomarker) for Parkinson's disease that's resulted from a project funded by The Michael J. Fox Foundation.

Learn more
Cleveland Clinic Joins 23andMe, Michael J. Fox Foundation in Search for Genetic Clues to PD

February 14, 2012

The Cleveland Clinic today announced that it is joining an ongoing effort from personal genetics company 23andMe to recruit 10,000 Parkinson’s disease (PD) patients to contribute their DNA

Learn more
San Diego Union Tribune Reports on PPMI

January 24, 2012

Today the San Diego Union Tribune featured a Q&A with Douglas Galasko, MD a principal investigator with the Parkinson's Progression Marker's Initiative (PPMI)

Learn more
Northwestern University PPMI Site Featured in the Chicago Tribune

January 18, 2012

Yesterday the Chicago Tribune profiled Delores Slezak, a nurse in Illinois, and her decision to participate in the Parkinson's Progression Marker's Initiative (PPMI).

Learn more
MJFF Research Staff Reflects on Some of 2011's Big Impact Projects

December 24, 2011

This week, the MJFF research staff reflected on some of the projects they worked on in 2011 that they believe could have the greatest impact on the Parkinson’s disease (PD) patient community.

Learn more